Role of ABCC5 in Gemcitabine Resistance in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid tumours. gemcitabine-based regimens have been used as front-line treatments for patients with advanced pancreatic cancer. gemcitabine may initially show a response, but most often multi-drug resistance (MDR) rapidly develops...
|Other Authors:||, ,|
Auckland University of Technology,
|Online Access:||Get fulltext|